MEDRADSC 3C03 Lecture Notes - Lecture 7: Non-Alcoholic Fatty Liver Disease, Coagulopathy, World Health Organization

• School: McMaster University
• Department: Medical Radiation Sciences
• Course: MEDRADSC 3C03
• Professor: Meaghan Jefferson

Document Summary

Every interventional imaging area will have a protocol manual that will cover: This material is very broad look at common procedures. World health organization: when is it indicated to run clotting assessments? (patient information - not type of test) Any indication of coagulopathy or abnormal clotting, or if they are on any blood thinners (or meds that thin the blood or decrease their ability to form clots) Especially needs to be considered when taking biopsies or core samples out of highly vascular regions (ie kidneys or liver) Minimizing hematomas or hemorrhage within the abdomen or peritoneum. Obtain tissue for molecular profiling - type of cancer. Presence of parenchymal disease (hepatitis) - impairing function of the organ. Determine nature of atypical or incidentally discovered mass that may or may not be malignant - majority of benign (ie hemangioma) Mass of unknown origin, diagnosing primary pathologies.